Company Data
Emmaus Life Sciences Incorporation
Ticker
EMMA
Current Price
$0.04 21.21%
Market Cap
$2.6M
Price Target
Refer to Report
Volume
169.8K
52wk Range
$0.0001 - $0.13215
Overview
Emmaus Life Sciences Inc is a biopharmaceutical company engaged in the discovery, development, and commercialization of new treatments and therapies primarily for rare and orphan diseases. The company’s commercial product is Endari, an oral pharmaceutical grade L-glutamine treatment indicated to reduce acute complications of sickle cell disease in adult and pediatric patients five years of age and older. Its products in the pipeline include Diverticulosis and Cell Sheet Engineering.